ArticleBMC cancer2025

Development and validation of the CHI-CAT score: a novel tool for assessing cancer-associated venous thromboembolism risk in China.

Xiaoli Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.